Atlas Trials

Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients

Clinical trial NCT03378479 · COMPLETED

Trial details

NCT number
NCT03378479
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Aspergillosis; Pulmonary, Invasive (Etiology)
Start date
2017-12-27
Primary completion
2020-03-31
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.